DW/BI FOR PHARMA. CONF., PHILADELPHIA, April 25 /PRNewswire-FirstCall/ -- Cognos (Nasdaq: COGN; TSX: CSN), the world leader in business intelligence and corporate performance management (CPM), announced today that Quintiles Transnational Corp. is standardizing on Cognos’ industry-leading BI series to provide its customers with in-depth, timely sales force performance and clinical product development analytics, as well as enable greater corporate reporting through executive scorecards.
Quintiles Transnational is the world’s leading provider of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Following a rigorous review of business intelligence solutions in the market, Quintiles selected Cognos to be the BI standard for two of its business units in particular -- Commercial Services, which provides customers with specialized pre-launch, launch and post-launch fee-for-service contract sales and strategic marketing services; and Product Development Services, which offers customers all phases of clinical research and outcomes research consulting.
Using Cognos BI, including Cognos ReportNet(TM) and Cognos PowerPlay(R), Commercial Services staff will be able to more effectively consolidate, analyze and report on sales data received from satellite offices around the world. Customers would then benefit from transparent, Web-based access to more timely sales performance reports, trends analysis and forecasts. Similarly, Product Development Services staff will leverage Cognos to improve the timeliness of operational reports and trends analysis that are tailored to the company’s clinical performance objectives. In addition, Quintiles will deploy Cognos Metrics Manager to help senior executives actively monitor and analyze results against key performance indicators.
“Our customers require timely, accurate and relevant information that can help them measure and analyze performance against program objectives,” said Marilee McTigue, vice president of IT strategy and planning at Quintiles Transnational. “With Cognos, operational as well as market information will be more transparent to the customer. Customers will also be able to personalize their view of their data, drill into their numbers, uncover trends and adjust their plans to improve performance.”
“Pharmaceutical companies face tremendous costs to support their research, development and sales and marketing initiatives. This fuels the need for effective performance management solutions that can drive cost savings, and maximize operational effectiveness,” said Bill Stevens, director of life sciences industry solutions at Cognos. “Cognos is very pleased to be working together with Quintiles. Coupling their expertise in pharmaceutical services with our leading business intelligence and performance analytics solutions will give their customers the competitive advantage they need to succeed.”
Cognos is one of the leading providers of BI and corporate performance management solutions for the pharmaceutical industry. Currently, 24 of the top 30 pharmaceutical firms rely on Cognos performance management software. For more information about Cognos solutions for pharmaceuticals and life sciences, please visit http://www.cognos.com/solutions/industry//pharmaceuticals-life- sciences/index.html.
ABOUT QUINTILES TRANSNATIONAL:
Quintiles helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles has offices in 50 countries and is the world’s leading pharmaceutical services organization. For more information visit the company’s Web site at http://www.quintiles.com/.
ABOUT COGNOS:
Cognos, the world leader in business intelligence and corporate performance management, delivers software and services that helps companies drive, monitor and understand corporate performance.
Cognos delivers the next level of competitive advantage -- Corporate Performance Management (CPM) -- achieved through the strategic application of BI on an enterprise scale. Our integrated CPM solution helps customers drive performance through planning; monitor performance through scorecarding; and understand performance through business intelligence.
Cognos serves more than 23,000 customers in over 135 countries. Cognos enterprise business intelligence solutions and services are also available from more than 3,000 worldwide partners and resellers. For more information, visit the Cognos Web site at http://www.cognos.com/.
Cognos and the Cognos logo are trademarks or registered trademarks of Cognos Incorporated in the United States and/or other countries. All other names are trademarks or registered trademarks of their respective companies.
Note to Editors: Copies of previous Cognos press releases and Corporate and product information are available on the Cognos Web site at http://www.cognos.com/ and at PR Newswire’s site at http://www.prnewswire.com/
Media Contacts: David DeRosa Cognos, 613-738-1338 ext. 3317 david.derosa@cognos.com Kristen Orfanos Lois Paul & Partners, LLC, 781-782-5852 kristen_orfanos@lpp.com Investor Relations: John Lawlor Cognos, 613-738-3503 john.lawlor@cognos.com
Cognos
CONTACT: David DeRosa, Media Contact, +1-613-738-1338 ext. 3317,david.derosa@cognos.com, or John Lawlor, Investor Relations, +1-613-738-3503,john.lawlor@cognos.com, both of Cognos; or Kristen Orfanos, Media Contact ofLois Paul & Partners, LLC, +1-781-782-5852, kristen_orfanos@lpp.com
Company News On-Call: http://www.prnewswire.com/comp/107867.html
